ArticleJACC. Case reports2025
Intravascular Lithotripsy With Ultra-Low Contrast OCT Guidance for Calcified Coronary Lesions in Advanced CKD Patients.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo demonstrate the feasibility and safety of optical coherence tomography (OCT)-guided, ultra-low contrast percutaneous coronary intervention with intravascular lithotripsy (IVL) for severely calcified coronary lesions in patients with advanced chronic kidney disease. KEY STEPS: As procedural steps: 1) use prior angiograms for procedural planning; 2) perform OCT with low-molecular weight dextran to assess calcium morphology; 3) apply IVL for targeted calcium modification; 4) reassess with OCT for calcium fracture, lumen gain, and stent optimization; and 5) limit total iodinated contrast volume to ≤10 mL. POTENTIAL PITFALLS: Potential issues include: 1) geographic stent miss when relying on fluoroscopic markers-use side-branch wiring for reference; 2) side-branch compromise-consider jailed balloon protection; 3) dextran-related allergic reaction-switch to intravascular ultrasound if needed; and 4) excessive dextran (>100 mL)-avoid to reduce renal risk. TAKE-HOME MESSAGE: OCT-guided ultra-low contrast percutaneous coronary intervention with IVL enables safe, precise treatment of heavily calcified lesions in advanced chronic kidney disease while minimizing renal injury risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.